TrimRX
US$ 27.39
glp 1 agonist with dpp 4 inhibitor The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect Glucagon-like peptide-1 - Wikipedia
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 68.Singh S., Chang H.Y., Richards T.M., Weiner J.P., Clark J.M., Segal J.B
Data Availability Statement This is a review article and does not include any original data
Teramoto, S
However, GLP-1 RAs significantly increased the change in the 6-min walk test (MWT) distance (MD: 19.74, p = 0.002)
Figure 1: Incidence Rate of all GLP-1 Agonists
Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program
